✦ LIBER ✦

Alemtuzumab in T-cell malignancies

✍ Scribed by Claire E. Dearden; Estella Matutes; Daniel Catovsky

Book ID: 111640872
Publisher: Springer US
Year: 2002
Tongue: English
Weight: 149 KB
Volume: 19
Category: Article
ISSN: 1357-0560
DOI: 10.1385/mo:19:2s:s27

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Role of Alemtuzumab in the Managemen

The Role of Alemtuzumab in the Management of T-Cell Malignancies

✍ Claire Dearden 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Variable CD52 expression in mature T cel

Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy

✍ Liuyan Jiang; Constance M. Yuan; Julia Hubacheck; John E. Janik; Wyndham Wilson; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Alemtuzumab in T-cell lymphoproliferativ

Alemtuzumab in T-cell lymphoproliferative disorders

✍ Claire E. Dearden; Estella Matutes 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Targeted therapies in T-cell malignancie

Targeted therapies in T-cell malignancies

✍ Anskar Y. H. Leung; Raymond Liang 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 239 KB

Cytogenetic studies in T-cell malignanci

Cytogenetic studies in T-cell malignancies

✍ Cristina Mecucci; Andries Louwagie; José Thomas; Marc Boogaerts; Herman Van Den 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Pharmacokinetics of alemtuzumab after ha

Pharmacokinetics of alemtuzumab after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab with or without CD52-positive malignancies

✍ Kumi Oshima; Yoshinobu Kanda; Fumio Nakahara; Eriko Shoda; Takahiro Suzuki; Yoic 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views